BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 21494059)

  • 1. CYP2D6 in the metabolism of opioids for mild to moderate pain.
    Leppert W
    Pharmacology; 2011; 87(5-6):274-85. PubMed ID: 21494059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of tramadol in cancer pain treatment--a review.
    Leppert W; Łuczak J
    Support Care Cancer; 2005 Jan; 13(1):5-17. PubMed ID: 15668743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tramadol as an analgesic for mild to moderate cancer pain.
    Leppert W
    Pharmacol Rep; 2009; 61(6):978-92. PubMed ID: 20081232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Weak opioids].
    Shiratsuchi T; Ogawa S
    Nihon Rinsho; 2001 Sep; 59(9):1795-9. PubMed ID: 11554054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Codeine/acetaminophen and hydrocodone/acetaminophen combination tablets for the management of chronic cancer pain in adults: a 23-day, prospective, double-blind, randomized, parallel-group study.
    Rodriguez RF; Castillo JM; Del Pilar Castillo M; Nuñez PD; Rodriguez MF; Restrepo JM; Rodriguez JM; Ortiz Y; Angel AM
    Clin Ther; 2007 Apr; 29(4):581-7. PubMed ID: 17617281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective study evaluating the response of patients with unrelieved cancer pain to parenteral opioids.
    Enting RH; Oldenmenger WH; van der Rijt CC; Wilms EB; Elfrink EJ; Elswijk I; Sillevis Smitt PA
    Cancer; 2002 Jun; 94(11):3049-56. PubMed ID: 12115396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of strong opioids in advanced cancer pain: a randomized trial.
    Marinangeli F; Ciccozzi A; Leonardis M; Aloisio L; Mazzei A; Paladini A; Porzio G; Marchetti P; Varrassi G
    J Pain Symptom Manage; 2004 May; 27(5):409-16. PubMed ID: 15120769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Weak" opioid analgesics. Codeine, dihydrocodeine and tramadol: no less risky than morphine.
    Prescrire Int; 2016 Feb; 25(168):45-50. PubMed ID: 27042732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of tramadol and dihydrocodeine treatment on quality of life of patients with cancer pain.
    Leppert W; Majkowicz M
    Int J Clin Pract; 2010 Nov; 64(12):1681-7. PubMed ID: 20946274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetics of opioids.
    Somogyi AA; Barratt DT; Coller JK
    Clin Pharmacol Ther; 2007 Mar; 81(3):429-44. PubMed ID: 17339873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of Cytochrome P450, Family 2, Subfamily D, Polypeptide 6 (CYP2D6) polymorphisms on pain sensitivity and clinical response to weak opioid analgesics.
    Zahari Z; Ismail R
    Drug Metab Pharmacokinet; 2014; 29(1):29-43. PubMed ID: 23759977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complicated pain management in a CYP450 2D6 poor metabolizer.
    Foster A; Mobley E; Wang Z
    Pain Pract; 2007 Dec; 7(4):352-6. PubMed ID: 17986163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paediatric cancer pain management using the WHO analgesic ladder--results of a prospective analysis from 2265 treatment days during a quality improvement study.
    Zernikow B; Smale H; Michel E; Hasan C; Jorch N; Andler W
    Eur J Pain; 2006 Oct; 10(7):587-95. PubMed ID: 16243549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pain management in patients with cancer: focus on opioid analgesics.
    Leppert W
    Curr Pain Headache Rep; 2011 Aug; 15(4):271-9. PubMed ID: 21479998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of the effect of opioid-related side effects on the undertreatment of moderate to severe chronic non-cancer pain: tapentadol, a step toward a solution?
    Candiotti KA; Gitlin MC
    Curr Med Res Opin; 2010 Jul; 26(7):1677-84. PubMed ID: 20465361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of CYP2D6 and OPRM1 pharmacogenetic testing for opioid therapy.
    Reynolds KK; Ramey-Hartung B; Jortani SA
    Clin Lab Med; 2008 Dec; 28(4):581-98. PubMed ID: 19059064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cancer pain management].
    Takeda F
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1031-7. PubMed ID: 2730006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chronic dizziness in a pain patient--pharmacogenomic identification of tramadol as cause].
    Eichhorn A; Barth J
    Rehabilitation (Stuttg); 2010 Dec; 49(6):393-5. PubMed ID: 21140323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pain management of musculoskeletal injuries in children: current state and future directions.
    Ali S; Drendel AL; Kircher J; Beno S
    Pediatr Emerg Care; 2010 Jul; 26(7):518-24; quiz 525-8. PubMed ID: 20622635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.